REVB insider transaction filings
REVELATION BIOSCIENCES, INC. — 28 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-18. Screen REVB transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-18 | 4 | CARVER JENNIFER — Director | Grant/award (A): 32,011 @ $0 | EDGAR |
| 2026-08-18 | 4 | ROPER JESS — Director | Grant/award (A): 32,011 @ $0 | EDGAR |
| 2026-08-18 | 4 | Zygmont Chester Stanley III — Chief Financial Officer | Grant/award (A): 208,073 @ $0 · Gift (G): 208,073 @ $0 · Gift (G): 208,073 @ $0 | EDGAR |
| 2026-08-18 | 4 | Chawla Lakhmir S — Director | Grant/award (A): 32,011 @ $0 | EDGAR |
| 2026-08-18 | 4 | Rolke James — Chief Executive Officer, Director | Grant/award (A): 208,076 @ $0 | EDGAR |
| 2026-05-01 | 4 | Zygmont Chester Stanley III — Chief Financial Officer | Tax withholding (F): 13,285 @ $1.10 | EDGAR |
| 2026-05-01 | 4 | Rolke James — Chief Executive Officer, Director | Tax withholding (F): 10,115 @ $1.13 | EDGAR |
| 2026-02-05 | 4 | Zygmont Chester Stanley III — Chief Financial Officer | Tax withholding (F): 13,100 @ $1.65 | EDGAR |
| 2026-02-05 | 4 | Rolke James — Chief Executive Officer, Director | Tax withholding (F): 8,521 @ $1.86 | EDGAR |
| 2026-02-05 | 4 | CARVER JENNIFER — Director | Tax withholding (F): 1,661 @ $1.87 | EDGAR |
| 2026-02-05 | 4 | Chawla Lakhmir S — Director | Tax withholding (F): 2,261 @ $1.85 | EDGAR |
| 2026-02-05 | 4 | ROPER JESS — Director | Tax withholding (F): 1,591 @ $1.85 | EDGAR |
| 2026-01-12 | 4 | Zygmont Chester Stanley III — Chief Financial Officer | Grant/award (A): 78,145 @ $0.90 | EDGAR |
| 2026-01-12 | 4 | Rolke James — Chief Executive Officer, Director | Grant/award (A): 532,829 @ $0.90 | EDGAR |
| 2026-01-12 | 4 | CARVER JENNIFER — Director | Grant/award (A): 41,981 @ $0.90 | EDGAR |
| 2026-01-12 | 4 | Chawla Lakhmir S — Director | Grant/award (A): 41,981 @ $0.90 | EDGAR |
| 2026-01-12 | 4 | ROPER JESS — Director | Grant/award (A): 41,981 @ $0.90 | EDGAR |
| 2025-10-31 | 4 | Zygmont Chester Stanley III — Chief Financial Officer | Grant/award (A): 390,614 @ $1.28 | EDGAR |
| 2025-10-31 | 4 | Rolke James — Chief Executive Officer, Director | Grant/award (A): 390,614 @ $1.28 | EDGAR |
| 2025-10-31 | 4 | CARVER JENNIFER — Director | Grant/award (A): 15,625 @ $1.28 | EDGAR |
| 2025-10-31 | 4 | Chawla Lakhmir S — Director | Grant/award (A): 15,625 @ $1.28 | EDGAR |
| 2025-10-31 | 4 | ROPER JESS — Director | Grant/award (A): 15,625 @ $1.28 | EDGAR |
| 2025-02-13 | 4 | Zygmont Chester Stanley III — Chief Financial Officer | Grant/award (A): 15,048 @ $3.87 | EDGAR |
| 2025-02-13 | 4 | Rolke James — Chief Executive Officer, Director | Grant/award (A): 30,095 @ $3.87 | EDGAR |
| 2025-02-13 | 4 | CARVER JENNIFER — Director | Grant/award (A): 181 @ $3.87 | EDGAR |
| 2025-02-13 | 4 | Chawla Lakhmir S — Director | Grant/award (A): 181 @ $3.87 | EDGAR |
| 2025-02-13 | 4 | ROPER JESS — Director | Grant/award (A): 181 @ $3.87 | EDGAR |
| 2025-02-13 | 4 | TIDMARSH GEORGE F — Director | Grant/award (A): 181 @ $3.87 | EDGAR |
Recent 8-K events — REVELATION BIOSCIENCES, INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-19 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-13 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-24 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-01 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-19 | 8-K | 3.03 — Material Modification to Rights of Security Holders 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-26 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-29 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 3.03 — Material Modification to Rights of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-22 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=REVB returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →